Angiovist 370 and Quit smoking - a phase IV clinical study of FDA data
We study 87,260 people who take Angiovist 370 or have Quit smoking. No report of Quit smoking is found in people who take Angiovist 370.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Angiovist 370?
Angiovist 370 has active ingredients of diatrizoate meglumine; diatrizoate sodium.
What is Quit Smoking?
Quit smoking is found to be associated with 1,276 drugs and 873 conditions by eHealthMe.
Do you take Angiovist 370 and have Quit smoking?Check whether Quit smoking is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quit smoking and when was it recovered:
Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:
Alternative drugs to, pros and cons of Angiovist 370:
Quit smoking treatments and more:
- Quit smoking (87,260 reports)
COVID vaccines that are related to Quit smoking:
- Quit smoking in Moderna COVID Vaccine
- Quit smoking in Pfizer BioNTech Covid Vaccine
- Quit smoking in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Quit smoking:
All the conditions that are associated with Quit smoking:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Angiovist 370) and Angiovist 370 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Humira and Cardiac Murmur - 3 seconds ago
- Atripla and Erection Problems - 3 seconds ago
- Buspar and Appetite - Increased - 5 seconds ago
- Advil and Tagrisso drug interaction - 6 seconds ago
- Phenytoin Sodium and Hyperthyroidism - 8 seconds ago
- Sulfatrim and Nausea - 18 seconds ago
- Prednisone and Abnormal Dreams - 19 seconds ago
- Panic Disorder and Arrhythmias - 26 seconds ago
- Tramadol and Compazine drug interaction - 33 seconds ago
- Losartan and Keratorhexis - 58 seconds ago